For: | Zhang XF, Bian JC, Zhang XY, Zhang ZM, Jiang F, Wang QM, Wang QJ, Cao YY, Tang BM. Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? World J Gastroenterol 2005; 11(10): 1457-1462 [PMID: 15770721 DOI: 10.3748/wjg.v11.i10.1457] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1457.htm |
Number | Citing Articles |
1 |
Giuliano Di Pietro, Sandra Rocha Gadelha, Sandra Mara Bispo Sousa, Paulo Roberto Santana de Melo, Fabricio Rios Santos. N-acetyltransferase 2: Slow, intermediate or fast? A booming question of the molecular epidemiology in cancer research. Open Journal of Genetics 2012; 2(04): 221 doi: 10.4236/ojgen.2012.24028
|
2 |
Md. Rezaul Islam, Abdur Rauf, Shopnil Alash, Md Naeem Hossain Fakir, Gazi Kaifeara Thufa, Mahbuba Sharmin Sowa, Dattatreya Mukherjee, Harendra Kumar, Md Sadique Hussain, Abdullah S. M. Aljohani, Muhammad Imran, Waleed Al Abdulmonem, Rekha Thiruvengadam, Muthu Thiruvengadam. A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways. Medical Oncology 2024; 41(6) doi: 10.1007/s12032-024-02333-5
|
3 |
YOUYANG ZHENG, YONG LI, YAOSHU TENG, ZHEN ZHANG, XIAOLIN CAO. Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis. Oncology Letters 2012; 3(2): 429 doi: 10.3892/ol.2011.493
|
4 |
Semra Demokan, Yusufhan Suoglu, Mustafa Gözeler, Deniz Demir, Nejat Dalay. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. Molecular Biology Reports 2010; 37(7): 3217 doi: 10.1007/s11033-009-9905-8
|
5 |
Fei Jin, Li-Shuai Qu, Xi-Zhong Shen. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagnostic Pathology 2009; 4(1) doi: 10.1186/1746-1596-4-39
|
6 |
N.R. Malge, A.M.P.W. Bandara, W.L.R. Keerthirathna, D.M.I. Dissanayake, Patharage Kamal Perera, Chamindri Witharana, L.D.C. Peiris. Antioxidant and Anti-proliferative Activities of Smilax Zeylanica Root and Rhizome Extract against Liver Carcinoma Cells. Journal of Herbs, Spices & Medicinal Plants 2021; 27(2): 188 doi: 10.1080/10496475.2021.1891178
|
7 |
Neville J. Butcher, Rodney F. Minchin, Arthur Christopoulos. ArylamineN-Acetyltransferase 1: A Novel Drug Target in Cancer Development. Pharmacological Reviews 2012; 64(1): 147 doi: 10.1124/pr.110.004275
|
8 |
Mariam R. Habil, Raúl A. Salazar-González, Mark A. Doll, David W. Hein. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes. Archives of Toxicology 2022; 96(12): 3257 doi: 10.1007/s00204-022-03381-4
|